▶ 調査レポート

生物学的表示器の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Biological Indicators Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。生物学的表示器の世界市場 2020年:企業別、地域別、種類・用途別 / Global Biological Indicators Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-14916資料のイメージです。• レポートコード:D0804-14916
• 出版社/出版日:GlobalInfoResearch / 2020年7月21日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、生物学的表示器の世界市場を広く調査・分析し、今後の市場展望をまとめております。生物学的表示器の種類別市場規模(自己完結型生物表示器、生物表示ストリップ)、用途別市場規模(病院、製薬企業、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):3M、Hu-Friedy、Mesa Laboratories、Getinge Group、Matachana、Cantel Medical、Bag Health Care、Fuze Medical、Steris、Advanced Sterilization、Terragene、Andersen、GKE
・地域別グローバル市場分析 2015年-2020年
・生物学的表示器の北米市場(アメリカ、カナダ、メキシコ)
・生物学的表示器のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・生物学的表示器のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・生物学的表示器の南米市場(ブラジル、アルゼンチン)
・生物学的表示器の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:自己完結型生物表示器、生物表示ストリップ
・用途別分析:病院、製薬企業、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Biological Indicators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Biological Indicators sales will be xx in 2020 from Biological Indicators million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Biological Indicators market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Biological Indicators industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Biological Indicators and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Biological Indicators market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biological Indicators market has been segmented into:
Self-Contained Biological Indicator
Biological Indicator Strip

By Application, Biological Indicators has been segmented into:
Hospital
Pharma Companies
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biological Indicators market presented in the report. This section sheds light on the sales growth of different regional and country-level Biological Indicators markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biological Indicators market.

The report offers in-depth assessment of the growth and other aspects of the Biological Indicators market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Biological Indicators Market Share Analysis
Biological Indicators competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biological Indicators sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biological Indicators sales, revenue and market share for each player covered in this report.

The major players covered in Biological Indicators are:
3M
Hu-Friedy
Mesa Laboratories
Getinge Group
Matachana
Cantel Medical
Bag Health Care
Fuze Medical
Steris
Advanced Sterilization
Terragene
Andersen
GKE

レポート目次

1 Biological Indicators Market Overview
1.1 Product Overview and Scope of Biological Indicators
1.2 Classification of Biological Indicators by Type
1.2.1 Global Biological Indicators Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biological Indicators Revenue Market Share by Type in 2019
1.2.3 Self-Contained Biological Indicator
1.2.4 Biological Indicator Strip
1.3 Global Biological Indicators Market by Application
1.3.1 Overview: Global Biological Indicators Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Other
1.4 Global Biological Indicators Market by Regions
1.4.1 Global Biological Indicators Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biological Indicators (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biological Indicators Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biological Indicators Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biological Indicators Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biological Indicators Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biological Indicators Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Biological Indicators Industry Impact
1.5.1 COVID-19 Potential Implications for the Biological Indicators
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Biological Indicators
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 3M
2.1.1 3M Details
2.1.2 3M Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 3M SWOT Analysis
2.1.4 3M Product and Services
2.1.5 3M Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hu-Friedy
2.2.1 Hu-Friedy Details
2.2.2 Hu-Friedy Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hu-Friedy SWOT Analysis
2.2.4 Hu-Friedy Product and Services
2.2.5 Hu-Friedy Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mesa Laboratories
2.3.1 Mesa Laboratories Details
2.3.2 Mesa Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mesa Laboratories SWOT Analysis
2.3.4 Mesa Laboratories Product and Services
2.3.5 Mesa Laboratories Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.4 Getinge Group
2.4.1 Getinge Group Details
2.4.2 Getinge Group Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Getinge Group SWOT Analysis
2.4.4 Getinge Group Product and Services
2.4.5 Getinge Group Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.5 Matachana
2.5.1 Matachana Details
2.5.2 Matachana Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Matachana SWOT Analysis
2.5.4 Matachana Product and Services
2.5.5 Matachana Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cantel Medical
2.6.1 Cantel Medical Details
2.6.2 Cantel Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cantel Medical SWOT Analysis
2.6.4 Cantel Medical Product and Services
2.6.5 Cantel Medical Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bag Health Care
2.7.1 Bag Health Care Details
2.7.2 Bag Health Care Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bag Health Care SWOT Analysis
2.7.4 Bag Health Care Product and Services
2.7.5 Bag Health Care Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fuze Medical
2.8.1 Fuze Medical Details
2.8.2 Fuze Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fuze Medical SWOT Analysis
2.8.4 Fuze Medical Product and Services
2.8.5 Fuze Medical Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.9 Steris
2.9.1 Steris Details
2.9.2 Steris Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Steris SWOT Analysis
2.9.4 Steris Product and Services
2.9.5 Steris Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.10 Advanced Sterilization
2.10.1 Advanced Sterilization Details
2.10.2 Advanced Sterilization Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Advanced Sterilization SWOT Analysis
2.10.4 Advanced Sterilization Product and Services
2.10.5 Advanced Sterilization Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.11 Terragene
2.11.1 Terragene Details
2.11.2 Terragene Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Terragene SWOT Analysis
2.11.4 Terragene Product and Services
2.11.5 Terragene Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.12 Andersen
2.12.1 Andersen Details
2.12.2 Andersen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Andersen SWOT Analysis
2.12.4 Andersen Product and Services
2.12.5 Andersen Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
2.13 GKE
2.13.1 GKE Details
2.13.2 GKE Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GKE SWOT Analysis
2.13.4 GKE Product and Services
2.13.5 GKE Biological Indicators Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biological Indicators Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biological Indicators Players Market Share
3.2.2 Top 10 Biological Indicators Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biological Indicators Revenue and Market Share by Regions
4.2 North America Biological Indicators Revenue and Growth Rate (2015-2020)
4.3 Europe Biological Indicators Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biological Indicators Revenue and Growth Rate (2015-2020)
4.5 South America Biological Indicators Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biological Indicators Revenue and Growth Rate (2015-2020)
5 North America Biological Indicators Revenue by Countries
5.1 North America Biological Indicators Revenue by Countries (2015-2020)
5.2 USA Biological Indicators Revenue and Growth Rate (2015-2020)
5.3 Canada Biological Indicators Revenue and Growth Rate (2015-2020)
5.4 Mexico Biological Indicators Revenue and Growth Rate (2015-2020)
6 Europe Biological Indicators Revenue by Countries
6.1 Europe Biological Indicators Revenue by Countries (2015-2020)
6.2 Germany Biological Indicators Revenue and Growth Rate (2015-2020)
6.3 UK Biological Indicators Revenue and Growth Rate (2015-2020)
6.4 France Biological Indicators Revenue and Growth Rate (2015-2020)
6.5 Russia Biological Indicators Revenue and Growth Rate (2015-2020)
6.6 Italy Biological Indicators Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biological Indicators Revenue by Countries
7.1 Asia-Pacific Biological Indicators Revenue by Countries (2015-2020)
7.2 China Biological Indicators Revenue and Growth Rate (2015-2020)
7.3 Japan Biological Indicators Revenue and Growth Rate (2015-2020)
7.4 Korea Biological Indicators Revenue and Growth Rate (2015-2020)
7.5 India Biological Indicators Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biological Indicators Revenue and Growth Rate (2015-2020)
8 South America Biological Indicators Revenue by Countries
8.1 South America Biological Indicators Revenue by Countries (2015-2020)
8.2 Brazil Biological Indicators Revenue and Growth Rate (2015-2020)
8.3 Argentina Biological Indicators Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biological Indicators by Countries
9.1 Middle East & Africa Biological Indicators Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biological Indicators Revenue and Growth Rate (2015-2020)
9.3 UAE Biological Indicators Revenue and Growth Rate (2015-2020)
9.4 Egypt Biological Indicators Revenue and Growth Rate (2015-2020)
9.5 South Africa Biological Indicators Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biological Indicators Revenue and Market Share by Type (2015-2020)
10.2 Global Biological Indicators Market Forecast by Type (2019-2024)
10.3 Self-Contained Biological Indicator Revenue Growth Rate (2015-2025)
10.4 Biological Indicator Strip Revenue Growth Rate (2015-2025)
11 Global Biological Indicators Market Segment by Application
11.1 Global Biological Indicators Revenue Market Share by Application (2015-2020)
11.2 Biological Indicators Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Pharma Companies Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Biological Indicators Market Size Forecast (2021-2025)
12.1 Global Biological Indicators Market Size Forecast (2021-2025)
12.2 Global Biological Indicators Market Forecast by Regions (2021-2025)
12.3 North America Biological Indicators Revenue Market Forecast (2021-2025)
12.4 Europe Biological Indicators Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biological Indicators Revenue Market Forecast (2021-2025)
12.6 South America Biological Indicators Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biological Indicators Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Biological Indicators Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biological Indicators by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biological Indicators Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biological Indicators Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Biological Indicators Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. 3M Corporate Information, Location and Competitors
Table 7. 3M Biological Indicators Major Business
Table 8. 3M Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 9. 3M SWOT Analysis
Table 10. 3M Biological Indicators Product and Solutions
Table 11. 3M Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Hu-Friedy Corporate Information, Location and Competitors
Table 13. Hu-Friedy Biological Indicators Major Business
Table 14. Hu-Friedy Biological Indicators Total Revenue (USD Million) (2018-2019)
Table 15. Hu-Friedy SWOT Analysis
Table 16. Hu-Friedy Biological Indicators Product and Solutions
Table 17. Hu-Friedy Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Mesa Laboratories Corporate Information, Location and Competitors
Table 19. Mesa Laboratories Biological Indicators Major Business
Table 20. Mesa Laboratories Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 21. Mesa Laboratories SWOT Analysis
Table 22. Mesa Laboratories Biological Indicators Product and Solutions
Table 23. Mesa Laboratories Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Getinge Group Corporate Information, Location and Competitors
Table 25. Getinge Group Biological Indicators Major Business
Table 26. Getinge Group Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 27. Getinge Group SWOT Analysis
Table 28. Getinge Group Biological Indicators Product and Solutions
Table 29. Getinge Group Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Matachana Corporate Information, Location and Competitors
Table 31. Matachana Biological Indicators Major Business
Table 32. Matachana Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 33. Matachana SWOT Analysis
Table 34. Matachana Biological Indicators Product and Solutions
Table 35. Matachana Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Cantel Medical Corporate Information, Location and Competitors
Table 37. Cantel Medical Biological Indicators Major Business
Table 38. Cantel Medical Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 39. Cantel Medical SWOT Analysis
Table 40. Cantel Medical Biological Indicators Product and Solutions
Table 41. Cantel Medical Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Bag Health Care Corporate Information, Location and Competitors
Table 43. Bag Health Care Biological Indicators Major Business
Table 44. Bag Health Care Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 45. Bag Health Care SWOT Analysis
Table 46. Bag Health Care Biological Indicators Product and Solutions
Table 47. Bag Health Care Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Fuze Medical Corporate Information, Location and Competitors
Table 49. Fuze Medical Biological Indicators Major Business
Table 50. Fuze Medical Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 51. Fuze Medical SWOT Analysis
Table 52. Fuze Medical Biological Indicators Product and Solutions
Table 53. Fuze Medical Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Steris Corporate Information, Location and Competitors
Table 55. Steris Biological Indicators Major Business
Table 56. Steris Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 57. Steris SWOT Analysis
Table 58. Steris Biological Indicators Product and Solutions
Table 59. Steris Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Advanced Sterilization Corporate Information, Location and Competitors
Table 61. Advanced Sterilization Biological Indicators Major Business
Table 62. Advanced Sterilization Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 63. Advanced Sterilization SWOT Analysis
Table 64. Advanced Sterilization Biological Indicators Product and Solutions
Table 65. Advanced Sterilization Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Terragene Corporate Information, Location and Competitors
Table 67. Terragene Biological Indicators Major Business
Table 68. Terragene Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 69. Terragene SWOT Analysis
Table 70. Terragene Biological Indicators Product and Solutions
Table 71. Terragene Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Andersen Corporate Information, Location and Competitors
Table 73. Andersen Biological Indicators Major Business
Table 74. Andersen Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 75. Andersen SWOT Analysis
Table 76. Andersen Biological Indicators Product and Solutions
Table 77. Andersen Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. GKE Corporate Information, Location and Competitors
Table 79. GKE Biological Indicators Major Business
Table 80. GKE Biological Indicators Total Revenue (USD Million) (2017-2018)
Table 81. GKE SWOT Analysis
Table 82. GKE Biological Indicators Product and Solutions
Table 83. GKE Biological Indicators Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Global Biological Indicators Revenue (Million USD) by Players (2015-2020)
Table 85. Global Biological Indicators Revenue Share by Players (2015-2020)
Table 86. Global Biological Indicators Revenue (Million USD) by Regions (2015-2020)
Table 87. Global Biological Indicators Revenue Market Share by Regions (2015-2020)
Table 88. North America Biological Indicators Revenue by Countries (2015-2020)
Table 89. North America Biological Indicators Revenue Market Share by Countries (2015-2020)
Table 90. Europe Biological Indicators Revenue (Million USD) by Countries (2015-2020)
Table 91. Asia-Pacific Biological Indicators Revenue (Million USD) by Countries (2015-2020)
Table 92. South America Biological Indicators Revenue by Countries (2015-2020)
Table 93. South America Biological Indicators Revenue Market Share by Countries (2015-2020)
Table 94. Middle East and Africa Biological Indicators Revenue (Million USD) by Countries (2015-2020)
Table 95. Middle East and Africa Biological Indicators Revenue Market Share by Countries (2015-2020)
Table 96. Global Biological Indicators Revenue (Million USD) by Type (2015-2020)
Table 97. Global Biological Indicators Revenue Share by Type (2015-2020)
Table 98. Global Biological Indicators Revenue Forecast by Type (2021-2025)
Table 99. Global Biological Indicators Revenue by Application (2015-2020)
Table 100. Global Biological Indicators Revenue Share by Application (2015-2020)
Table 101. Global Biological Indicators Revenue Forecast by Application (2021-2025)
Table 102. Global Biological Indicators Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biological Indicators Picture
Figure 2. Global Biological Indicators Revenue Market Share by Type in 2019
Figure 3. Self-Contained Biological Indicator Picture
Figure 4. Biological Indicator Strip Picture
Figure 5. Biological Indicators Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Pharma Companies Picture
Figure 8. Other Picture
Figure 9. Global Biological Indicators Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Biological Indicators Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biological Indicators Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Biological Indicators Revenue Market Share in 2019
Figure 18. Global Top 10 Players Biological Indicators Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Biological Indicators Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Biological Indicators Revenue Market Share by Regions (2015-2020)
Figure 22. Global Biological Indicators Revenue Market Share by Regions in 2018
Figure 23. North America Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 24. Europe Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 26. South America Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 28. North America Biological Indicators Revenue Market Share by Countries (2015-2020)
Figure 29. North America Biological Indicators Revenue Market Share by Countries in 2019
Figure 30. USA Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 31. Canada Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 33. Europe Biological Indicators Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Biological Indicators Revenue Market Share by Countries in 2019
Figure 35. Germany Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 36. UK Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 37. France Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 38. Russia Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 39. Italy Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Biological Indicators Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Biological Indicators Revenue Market Share by Countries in 2019
Figure 42. China Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 43. Japan Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 44. Korea Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 45. India Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 47. South America Biological Indicators Revenue Market Share by Countries (2015-2020)
Figure 48. South America Biological Indicators Revenue Market Share by Countries in 2019
Figure 49. Brazil Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Biological Indicators Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Biological Indicators Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 54. UAE Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Biological Indicators Revenue and Growth Rate (2015-2020)
Figure 57. Global Biological Indicators Revenue Share by Type (2015-2020)
Figure 58. Global Biological Indicators Revenue Share by Type in 2019
Figure 59. Global Biological Indicators Market Share Forecast by Type (2021-2025)
Figure 60. Global Self-Contained Biological Indicator Revenue Growth Rate (2015-2020)
Figure 61. Global Biological Indicator Strip Revenue Growth Rate (2015-2020)
Figure 62. Global Biological Indicators Revenue Share by Application (2015-2020)
Figure 63. Global Biological Indicators Revenue Share by Application in 2019
Figure 64. Global Biological Indicators Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Pharma Companies Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Biological Indicators Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Biological Indicators Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Biological Indicators Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Biological Indicators Revenue Market Forecast (2021-2025)
Figure 72. Europe Biological Indicators Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Biological Indicators Revenue Market Forecast (2021-2025)
Figure 74. South America Biological Indicators Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Biological Indicators Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel